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1044Objective: Rewarming and reanimating the donor heart from cold static storage predisposes the organ to injury
and graft dysfunction. Our main aim was to investigate the effects of 5 minutes of continuous rewarming with
a normokalemic, oxygenated, polarizing adenosine–lidocaine arrest solution after 6 hours of cold static storage
(4C) in adenosine–lidocaine or Celsior (Genzyme Corp, Cambridge, Mass) solutions.
Methods: Male Sprague–Dawley rats (350–450 g, n ¼ 40) were randomly assigned to one of 5 groups: (1) aden-
osine–lidocaine cold arrest with modified Krebs–Henseleit rewarming, (2) adenosine–lidocaine cold arrest with
adenosine–lidocaine rewarming, (3) Celsior cold arrest with Celsior rewarming, (4) Celsior cold arrest with
Krebs–Henseleit, and (5) Celsior cold arrest with adenosine–lidocaine arrest rewarming. Hearts were perfused
in working mode, arrested (37C), removed and stored for 6 hours at 4C, reattached in Langendorff mode,
and rewarmed for 5 minutes (37C). Hearts were switched to working mode, and function was compared with
prestorage values. Myocardial oxygen consumption and effluent lactate and pH values were measured during re-
warming and recovery.
Results: Cold adenosine–lidocaine hearts rewarmed with Krebs–Henseleit recovered 40% aortic flow and 58%
coronary flow at 60 minutes of reperfusion. Rewarming with adenosine–lidocaine arrest solution led to signifi-
cantly higher aortic flow (63%) and coronary flow (77%) at 60 minutes. Cold Celsior hearts rewarmed with Cel-
sior had 9 times higher effluent lactate values with acidosis (pH 6.5) during the last minute of rewarming
compared with all groups, and this was associated with early myocardial, vascular, and electrical stunning. At
5 and 10 minutes of recovery, the aortic flow was 1.0 and 8 mL/min, respectively. If cold Celsior hearts were
rewarmed with adenosine–lidocaine, they generated 18-fold higher aortic flow and 16-fold higher coronary
flow at 5 minutes. At 60 minutes, cold Celsior with Celsior-rewarmed hearts recovered 35% aortic flow and
50% coronary flow compared with 44% aortic flow and 67% coronary flow (P< .05) for Celsior with adeno-
sine–lidocaine–rewarmed hearts. Celsior with Krebs–Henseleit–rewarmed hearts recovered 39% aortic flow and
51% coronary flow and were not significantly different from Celsior-rewarmed hearts. The myocardial oxygen
consumption in the last minute of rewarming was 1.6 times higher for cold adenosine–lidocaine hearts rewarmed
with adenosine–lidocaine compared with cold Celsior and Celsior hearts (19 vs 12 mmol O2/min/g dry weight)
along with low lactate values and no acidosis.
Conclusions: Rewarming the rat heart after cold static storage in polarizing adenosine–lidocaine arrest solution
resulted in significantly higher aortic flow, coronary flow, and cardiac output compared with that seen after
Krebs–Henseleit or Celsior rewarming. Rewarming cold Celsior hearts with adenosine–lidocaine solution re-
duced stunning. Adenosine–lidocaine cardioplegia might offer a new reperfusion strategy after cold static storage.
(J Thorac Cardiovasc Surg 2011;141:1044-55)Over the past 3 decades, the design of organ-preservation
solutions has been based on 3 fundamental principles: (1)
hyperkalemic arrest, (2) a suitable cold ischemic milieu toe Heart Research Laboratory, Department of Physiology and Pharmacology,
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The Journal of Thoracic and Cardiovascular Surmaintain cell viability, and (3) protection from reperfusion
injury.1-3 Hyperkalemic arrest depolarizes the cell
membrane and places the heart in a highly vulnerable
state, which can damage the myocardium and coronary
microvasculature, leading to cellular Ca2þ loading,
vasoconstriction and spasm, arrhythmias, and atrial and
ventricular stunning.2-7 The untoward effects of high
potassium are further exacerbated by global ischemia
during cold static storage temperatures and by regional
ischemia during rewarming and implantation,6 which
together can contribute to graft injury and rejection.8
Over the last 10 years, our laboratory has focused on
developing a normokalemic nondepolarizing cardioplegiagery c April 2011
Abbreviations and Acronyms
AF ¼ aortic flow
AL ¼ adenosine–lidocaine
ATP ¼ adenosine triphosphate
CF ¼ coronary flow
KH ¼ Krebs–Henseleit
MVO2 ¼ myocardial oxygen consumption
Rudd and Dobson Evolving Technology/Basic Science
E
T
/B
Sin the rat model that clamps the membrane potential closer to
its resting voltage of around83 mV by using adenosine and
lidocaine (AL) as the active arrest composition.5-7 The idea
was borrowed from natural hibernators and places the heart
in a more natural state of suspended animation.9 In 2009, the
concept of polarized arrest was extended to orthotopic heart
transplantation,6 and we showed in the isolated rat heart that
AL was versatile as a preservation solution at both cold static
storage (4C) and warmer intermittent perfusion (28C–
30C) compared with Celsior solution (Genzyme Corp,
Cambridge, Mass).6 In 2010, we further showed that AL car-
dioplegia at 32C to 33C demonstrated superior arrest and
functional recovery profiles when the membrane potential
was maintained around the resting cell voltage compared
with pathological hyperpolarized hypokalemic (<3 mmol/
L) or depolarized hyperkalemic (10 and 16 mmol/L Kþ) ar-
rest states.7
The basic electrophysiology behind polarized versus
depolarized arrest is that at resting diastolic membrane po-
tentials, there are fewer open membrane channels, pores,
and exchangers compared with those at depolarized
states.5,7,10,11 The adverse effects of using depolarizing
potassium at50 mV is that many voltage-dependent mem-
brane channels (Ca2þ, Naþ window current, and Kþ), pores,
and exchangers (Naþ/Hþand Naþ/Ca2þ) are activated, which,
over time, can lead to Naþ and Ca2þ loading and cell injury
and possibly death.5,10,11 Maintaining a polarized
membrane also appears to have anti-inflammatory proper-
ties. Ward and colleagues12 showed, for example, that emi-
grated neutrophils, after adhering to rat ventricular
myocytes, caused an immediate membrane depolarization,
which contributed to an inflammatory-linked generation of
arrhythmias, tissue injury, and contractile dysfunction.
However, when they held the cell membrane potential
around the natural resting polarized state, they demonstrated
reduced damage from inflammatory attack. Despite showing
AL cardioprotection during polarized arrest and recovery,5-7
we have not investigated the benefits of warm AL
cardioplegia for reperfusion immediately after cold static
storage before normothermic spontaneous reanimation.
The aim of the present study was to investigate the effects
of early reperfusion after 6 hours of cold static storage by
using normokalemic, oxygenated, polarizing AL arrestThe Journal of Thoracic and Carsolution in the isolated rat heart. Hearts preserved for
6 hours at 4C in AL cardioplegia or Celsior were
reperfused and rewarmed for 5 minutes with either Krebs–
Henseleit (KH; polarizing nonarrest), AL (polarizing
arrest), or Celsior (depolarizing arrest) solutions before
being switched to working mode to compare their
functional recoveries.
MATERIALS AND METHODS
Animals
Male Sprague–Dawley rats (350–450 g, n ¼ 40) were obtained from
James Cook University’s breeding colony. Animals were fed ad libitum
and housed in a 12-hour light/dark cycle. On the day of the experiment,
rats were anesthetized with an intraperitoneal injection of thiopentone so-
dium (Thiobarb, 60 mg/kg body weight; Jurox, Rutherford, Australia),
and the hearts were rapidly excised, as described by Dobson and Jones.5
Rats were handled in compliance with James Cook University Guidelines
(ethics approval no. A1084) and the ‘‘Guide for the care and use of labora-
tory animals’’ from the National Institutes of Health (publication no. 85-23,
revised 1985, and PHS publication 1996). Adenosine (A9251,>99% pu-
rity) and all other chemicals were obtained from Sigma Chemical Company
(Castle Hill, New South Wales, Australia). Lidocaine hydrochloride was
purchased as a 2% solution (ilium) from the local Pharmaceutical Supplies
(Lyppard, Queensland, Australia).
Composition of Modified KH Perfusion Buffer
The modified KH buffer contained 10 mmol/L glucose, 117 mmol/L
NaCl, 5.9 mmol/L KCl, 25 mmol/L NaHCO3, 1.2 mmol/L NaH2PO4,
1.12 mmol/L CaCl2 (free Ca
2þ ¼ 1.07 mmol/L), and 0.512 mmol/L
MgCl2 (free Mg
2þ¼ 0.5 mmol/L) at pH 7.4 and 37C. The perfusion buffer
was filtered by using a 1-mm membrane and then bubbled vigorously with
95% O2/5% CO2 to achieve a PO2 value of greater than 600 mm Hg. The
perfusion buffer was not recirculated.
Arrest Solutions for Normothermic Induction and
Cold Static Storage
AL solution. The AL cardioplegia contained 200 mmol/L adenosine
plus 500 mmol/L lidocaine in 10 mmol/L glucose containing KH buffer
(pH 7.7 at 37C), as described by Dobson and Jones.5 The solution was fil-
tered with 0.2-mm filters and maintained at 37C. The arrest solution was not
actively bubbled with 95% O2/5% CO2, hence the higher pH. The average
PO2 value of the AL solution was 140 mm Hg, and the PCO2 value was 5 to
10 mm Hg.
Celsior solution. The Celsior solution contained 100 mmol/L NaOH,
15 mmol/L KCl, 13 mmol/L MgCl2, 0.25 mmol/L CaCl2, 20 mmol/L
glutamic acid, 80 mmol/L lactobionic acid, 30 mmol/L histidine, and
3 mmol/L glutathione at pH 7.3. The solution was filtered with a 0.2-mm
filter, was not actively bubbled with 95% O2/5% CO2, and had an average
PO2 value of 149 mm Hg.
Arrest Solutions for 5-Minute Warm Reperfusion
After Cold Static Storage
The AL and Celsior arrest solutions were the same as described above,
except that they were actively bubbled with 95% O2/5% CO2 to achieve
a PO2 value of greater than 600 mm Hg and not recirculated. Nonarrest
modified KH was identical to the above.
Experimental Groups
Rats were randomly assigned to one of 5 groups (n ¼ 8 each group): (1)
AL cold (4C) static storage plus 5 minutes of rewarming KH reperfusion,diovascular Surgery c Volume 141, Number 4 1045
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place in cold static 
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FIGURE 1. Experimental protocol. Isolated rat hearts were placed in cold static storage for 6 hours in (1) adenosine–lidocaine (AL) polarizing cardioplegia or
(2) Celsior depolarizing preservation solutions and continuously rewarmed in Langendorff mode for 5 minutes with different oxygenated reperfusion strat-
egies (see the Materials and Methods section for details). KH, Krebs–Henseleit solution.
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reperfusion, (3) Celsior cold (4C) static storage plus 5 minutes of rewarming
Celsior arrest reperfusion, (4) Celsior cold (4C) static storage plus 5 minutes
of rewarming KH, and (5) Celsior cold (4C) static storage plus 5 minutes of
rewarming AL arrest reperfusion. After 5 minutes of rewarming, hearts were
switched to working mode and reperfused with modified KH buffer for 60
minutes. Celsior rewarming was not studied with AL cold storage because
Celsior solution was not designed as a normokalemic, normothermic reperfu-
sion solution.13 In their early study, Menasche and associates13 arrested rat
hearts with a hypothermic (4C) flush of Celsior solution, stored hearts for
5 hours at 4C, reattached the heart in Langendorff mode, and reperfused
with KH solution for 60 minutes. Celsior reperfusion was included in the Cel-
sior storage group because it was a simple extension of the storage condition
differing only in temperature and oxygenation before switching to working
mode reperfusion. Celsior cold storage has been reported to reduce injury
to the heart in the transition from cold to warm reperfusion.13
Langendorff and Working Rat Heart Preparation
Hearts were rapidly removed from anesthetized rats and placed in ice-
cold heparinized modified KH buffer. Details of heart preparation, attach-
ment, and perfusion were described in Rudd and Dobson.6 Briefly, hearts
were attached to a Langendorff apparatus and perfused at a pressure head
of 90 cm H2O (68 mm Hg). The pulmonary artery was not cannulated before
arrest and detaching the heart for cold static storage to prevent vessel wall
damage. The artery was cannulated during reattachment of the heart after
cold static storage for collection of coronary venous effluent and O2 con-
sumption measurements (see below). For working mode operation, a small
incision was made in the left atrial appendage, and a cannula was inserted
and sutured. The heart was then switched from the Langendorff apparatus
to working mode by switching the supply of perfusate from the aorta to
the left atrial cannula at a hydrostatic pressure of 10 cm H2O (preload)
and an afterload of 100 cm H2O (76 mm Hg). Hearts were stabilized for
15 minutes, and prearrest data were recorded before converting back to Lan-
gendorff mode before inducing normothermic arrest. In working mode the
perfusion buffer was not recirculated.
Heart rate, aortic pressure, coronary flow (CF), and aortic flow (AF)
were measured before and after 6 hours of arrest and cold static storage
(Figure 1). Aortic pressure was measured continuously with a pressure
transducer (ADI Instruments, Sydney, Australia) coupled to a MacLab 2e1046 The Journal of Thoracic and Cardiovascular Sur(ADI Instruments). Systolic and diastolic pressures and heart rates were
calculated from the pressure trace by using MacLab software. Arterial
and venous perfusate PO2 and PCO2 values and pH were measured with
a Bayer 865 blood gas machine (Siemens Diagnostics, Melbourne, Aus-
tralia). CF and AF were measured in volumetric cylinders. CF before
cold static storage was measured not directly from the pulmonary artery
but from pulmonary artery drainage with a volumetric flask placed below
the heart. No pacing or cardiac massage was used during the reanimation
phase in working mode. The working heart model was chosen because it
is ejecting fluid against a pressure head and performs pressure-by-
distance work in contrast to the nonejecting Langendorff model, which per-
forms no physical work. The key to isolated rat heart perfusions is a clean
apparatus that was maintained by flushing weekly with 5 L of 3% hydro-
gen peroxide and 1% glacial acetic acid solution followed by a thorough
rinse with 10 L of 18 megaohm water. The initial criteria for exclusion
of working hearts during the 15-minute equilibration period were a heart
rate of less than 200 beats/min, a systolic pressure of less than 100 mm
Hg, and a CF of less than 10 mL/min.
Cold Static Storage (4C) and Early Reperfusion
The method of cold static storage for rat hearts has been described by
Rudd and Dobson.6 Briefly, hearts were arrested at a constant pressure
head of 90 cm H2O (68 mm Hg) by using AL cardioplegia or Celsior solu-
tion for 5 minutes (50–100 mL) at 37C for their respective groups. Hearts
were gently removed from the apparatus and placed in a 50-mL tube con-
taining their respective air-equilibrated preservation solutions, and the
sealed tube was immersed in the water bath set at 4C for a period of 6 hours
(Figure 1). After 6 hours of cold static storage, the hearts were immediately
reattached to the perfusion apparatus, and fresh warm oxygenated solutions
(AL, KH, or Celsior) were used to reperfuse the heart in nonworking Lan-
gendorff mode at a pressure head of 90 cm H2O (68 mm Hg) for 5 minutes
(Figure 1); the heart’s surface temperature was 28C to 32C. The warm re-
perfusion period of 5 minutes was chosen because the first few minutes ap-
pear to be the most critical for optimal cardioprotection after ischemia.14
The heart’s surface temperature was measured with a Cole–Parmer therm-
istor–thermometer (8402-20; Cole–Parmer Instrument Co, Vernon Hills,
Ill), which was tucked under the left auricle. Hearts were then switched to
working mode and reperfused for 60 minutes at 37C by using oxygenated
glucose containing KH solution at pH 7.4. Hearts were allowed togery c April 2011
Rudd and Dobson Evolving Technology/Basic Sciencespontaneously return function during reperfusion and were not electrically
assisted if function did not return. Functional data (AF, CF, heart rate,
and systolic and diastolic pressures) were measured after 15 minutes of
equilibration immediately before arrest and at 5-, 10-, 15-, 30-, 45-, and
60-minute time points during the 60 minutes of reperfusion. This data
were compared with the baseline (prearrest) data for each group.E
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Myocardial oxygen consumption (MVO2; in micromoles of oxygen per
minute per gram of dry weight heart) was calculated by using equation 1, as
follows5:
MVO2 ¼ ðpaO2pvO2ÞðBpVpÞ 3
aO2
22:40
3
Coronary Flow
gm dry wt
3 1000
¼ mmHg
mmHg
3
ml=ml
ml=mol
3
ml=min
gm dry wt
3 1000
(1)
where PaO2 and PvO2 are the partial pressures of oxygen (in millimeters
of mercury) in the arterial and venous perfusion lines. Bp is the baromet-
ric pressure (760 mm Hg), and Vp is the water vapor pressure at 37C
(47.1 mm Hg). The molar volume for oxygen at standard temperature
and pressure was 22.40 mL/millimole.5 aO2 is the Bunsen solubility co-
efficient defined as that volume of oxygen gas dissolved in one milliliter
of solution at a specified temperature reduced to standard temperature
and pressure (OC, 760 mm Hg); the aO2 at 37C for human plasma
is 0.024 mL/mL.5 Coronary venous effluent was measured in milliliters
per minute, and heart weight was expressed as grams of dry weight. To-
tal tissue water (as a percentage) was determined by the difference in wet
weight and dry weight divided by wet weight and multiplied by 100.
Baseline or prearrest MVO2 values were not obtained because the pul-
monary artery was not cannulated before placing the heart in cold static
storage to avoid damage occurring to the vessel. In its place we used the
average baseline normothermic MVO2 values from isolated rat hearts of
the same age and weight measured in our laboratory. These prearrest
MVO2 data were measured in the 2009 cold static storage study of
Rudd and Dobson6 but were not included in that article. They are
representative of the prearrest state in the present study because they
were measured under identical conditions of equilibration, perfusion,
and temperature.6
Lactate Output During Warm Reperfusion
Coronary effluent (1.0–1.5 mL) was collected in small 1.5-mL Eppen-
dorf tubes during the last minute of the rewarming period and stored at
20C until analysis (approximately 2 weeks). Perfusate lactate values
were analyzed with the Cobas Integra 800 by using a colorimetric kit pur-
chased from Roche Diagnostics (Castle Hill, Australia). Output results
were in millimoles per liter and converted to micromoles per minute per
gram of dry weight by using effluent CF and heart weight as in equation
2, as follows:
Lactate ðmmol=min=g dry wtÞ ¼ Lactate ðmmol=mLÞ
3 Coronary flow ðmL=minÞ
3 1=Heart weight ðg dry wtÞ1
(2)
Calculation of Total Adenosine Triphosphate
Production During Warm Reperfusion
Total ATP ðmmol=g dry weight heartÞ ¼ ATPaerobicþATPanaerobic (3)
Adenosine triphosphate (ATP; aerobic) was defined as the total ATP
produced by means of mitochondrial oxidative phosphorylation, assumingThe Journal of Thoracic and Car1.0 mmol of O2 forms 6.0 mmol of ATP, for a P:O ratio of 3.0, according to
equation 4, as follows:
ATP ðaerobicÞ ¼ MVO2 ðmmol O2=min=g dry weightÞ
3 6 ð6mmol ATP=mmol O2Þ
(4)
ATP (anaerobic) was defined as the ATP produced from anaerobic
glycogenolytic metabolism, where 1 mmol glucosyl unit from glycogen
forms 2 mmol of lactate with the formation of 3 mmol of ATP. ATP (anaer-
obic) was calculated from lactate output by using equation 5, as follows:
ATP ðanaerobicÞ ¼ Lactate ðmmol=min=g dry weightÞ
3 3=2 ð3mmol ATP=2mmol lactateÞ (5)
The assumption here is that ATP generated anaerobically was principally
derived from endogenous heart glycogen. We believe the 3 ATP/2 lactate stoi-
chiometry is justified based on the high effluent lactate value and low pH (6.5)
from one of the groups (see the Results section). If exogenous glucose was the
principal anaerobic fuel, 2mmol of ATP per glucosyl unit would be formed for
2 mmol of lactate because hexokinase (EC 2.7.1.1) phosphorylates glucose to
glucose-6-phosphate requiring 1 mmol of ATP. The lactate and O2 consump-
tion measurements were taken during the last minute of the 5-minute rewarm-
ing period with the different oxygenated reperfusion solutions.
Statistical Analysis
All results are expressed as the mean  standard error of the mean. One-
way analysis of variance was used to compare rat weights, arrest times, and
times to first beat and AF. Two-way analysis of variance with repeated mea-
sures was used to compare recovery variables (eg, AF, systolic and diastolic
pressures, heart rate, and cardiac output [CO]) over multiple time points for
the different treatment groups. One-way analysis of variance was used to
compare recovery of variables at specific times points (5, 10, 30, 45, and
60 minutes) during reperfusion in working mode. Significance was then as-
sessed by using Bonferroni and Dunnett 2-way post hoc tests. The a level of
significance for all experiments was set at a P value of less than .05.
RESULTS
Functional properties before and after cold static storage
are shown in Table 1 and Figures 2 and 3. During
prearrest, there were no significant differences among the
5 groups in AF, CF, CO, heart rate, developed pressures,
or rate–pressure product (Table 1).
Recovery of Aortic Flow
At 5 minutes of reperfusion in working mode, the AL cold
group with KH and AL rewarming recovered 13% and 25%
of their prearrest values, respectively, and these increased to
21% and 42% at 10 minutes (Table 1 and Figure 2, A). In
contrast, hearts preserved in cold Celsior and rewarmed
with Celsior or KH each generated only 2% of prearrest
AF at 5 minutes, respectively. However, when rewarmed
with AL, the AF increased 18-fold at 5 minutes (Table 1
and Figure 2, A). At 10 minutes, AF in the cold Celsior so-
lution with Celsior and KH rewarming groups increased to
14% and 9% of prearrest values, respectively; however,
these recoveries were still one third to one half of the value
if rewarmed with AL. At 30 minutes, the cold AL group re-
warmed with KH solution increased AF by around 1.9-fold
and the AL rewarming group by about 1.4-fold, after which
the AF remained relatively stable (Table 1 and Figure 1, A).diovascular Surgery c Volume 141, Number 4 1047
TABLE 1. Functional parameters of isolated working rat hearts during different rewarming–reperfusion strategies after 6 hours of cold static
storage in polarizing adenosine–lidocaine or depolarizing Celsior solutions (see the Materials and Methods section for details)
6-h Arrest
Cold ArrestþRewarming
Treatment
Aortic flow (mL/min) Coronary flow (mL/min)
n Value % PA Value % PA
15-min Prearrest AL 6-h arrest
þKrebs–Henseleit 8 62  5 24  2
þAL cardioplegia 8 65  2 22  2
Celsior 6-h arrest
þCelsior rewarming 8 57  3 22  2
þKrebs–Henseleit 8 67  2 22  1
þAL cardioplegia 8 59  2 21  1
5-min Recovery AL 6-h arrest
þKrebs–Henseleit 8 8  2 13 14  1 58
þAL cardioplegia 8 16  5* 25* 8  3 36
Celsior 6-h arrest
þCelsior rewarming 8 1  1z 2z 2  2z,x 9z,x
þKrebs Henseleit 8 1  1 2 12  1 55
þAL cardioplegia 8 18  4k 31k 16  1 76
10-min Recovery AL 6-h arrest
þKrebs–Henseleit 8 13  3 21 14  1 58
þAL cardioplegia 8 27  3* 42* 17  1* 77*
Celsior 6-h arrest
þCelsior rewarming 8 8  6 14 9  4z 41z
þKrebs–Henseleit 8 6  3 9 12  1 55
þAL cardioplegia 8 16  3k 27k 15  1 71
30-min Recovery AL 6-h arrest
þKrebs–Henseleit 8 25  1 40 14  1 58
þAL cardioplegia 8 39  2*,y 60*,y 16  1* 73 *
Celsior 6-h arrest
þCelsior rewarming 8 18  7z 32z 11  2 50
þKrebs–Henseleit 8 23  4 34 13  1 59
þAL cardioplegia 8 25  3k 42k 14  1 67
60-min Recovery AL 6-h arrest
þKrebs–Henseleit 8 25  1 40 14  1 58
þAL cardioplegia 8 41  2*,y 63*,y 17  1* 77*
Celsior 6-h arrest
þCelsior rewarming 8 20  7 35 11  2 50
þKrebs–Henseleit 8 26  5 39 12  1 51
þAL cardioplegia 8 26  3 44 14  1 67
AL, Adenosine–lidocaine. *AL (cold storage) with AL (rewarming) and Celsior (cold storage) with Celsior (rewarming), P< .05. yAL (cold storage) with AL (rewarming) and
AL (cold storage) with Krebs –Henseleit (rewarming), P<.05. zCelsior (cold storage) with Celsior (rewarming) and Celsior (cold storage) with AL (rewarming), P<.05. xCelsior
(cold storage) with Celsior (rewarming) and Celsior (cold storage) with Krebs –Henseleit (rewarming), P< .05. kCelsior (cold storage) with AL (rewarming) and Celsior (cold
storage) with Krebs –Henseleit (rewarming), P< .05.
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There was a rapid spontaneous return of CF in the cold AL
groups rewarmed with KH and AL cardioplegia, with 58%
and 36% of prearrest values recovered at 5 minutes (Table 1
and Figure 2, B). However, the KH rewarming group did not
increase CF further at 10, 30, and 60 minutes of reperfusion.
The cold AL with AL rewarming increased CF over 2-fold at
10 minutes compared with 5 minutes and stabilized at 30 and
60 minutes of reperfusion (Figure 2, B). In direct contrast to
all other groups at 5 minutes, the cold Celsior with Celsior
rewarming recovered only 9% of prearrest CF. However, re-
warming cold Celsior with KH or AL arrest solution led to
significantly higher 55% and 76% recovery of AF at 5 min-1048 The Journal of Thoracic and Cardiovascular Surutes (Table 1). At 10 minutes, the cold Celsior with Celsior
rewarming increased CF from 2 to 9 mL/min (41% base-
line), and as with KH or AL rewarming, it did not increase
further over the 60-minute reperfusion period (Table 1 and
Figure 2, B).
Recovery of Cardiac Output
The cold AL group rewarmed with KH and AL cardiople-
gia returned 27% and 28% of prearrest cardiac output (CO),
respectively, at 5 minutes, whereas CO in the KH group
did not increase further at 10 minutes, and AL rewarming
increased it 1.8-fold (51% of prearrest value). At 30 and
60 minutes, cold AL with KH rewarming increased CO togery c April 2011
Cardiac output (mL/min) Heart rate (beats/min) Systolic pressure
(mm Hg)
Diastolic pressure
(mm Hg)
Rate–pressure product
(beats/mm Hg/min)Value % PA Value % PA
86  4 285  12 127  2 60  0 36,216  1692
87  3 282  7 124  2 60  0 35,064  1018
79  5 282  17 124  4 60  0 34,880  1511
90  2 284  6 130  0 60  0 36,969  810
80  2 280  10 128  1 60  0 35,613  1038
23  3 27 228  8 80 98  5 66  4 22,410  1579
24  7* 28* 109  32y 39y 71  20* 36  10y 9706  3905*,y
3  3z 4z 38  26z,x 13z,x 26  18z,x 15  9z,x 3051  3216z
13  2 14 178  17 63 87  4 62  4 15,863  2106
34  5 43 197  19 70 126  5 60  1k 24,774  2382
27  3 31 242  15 85 98  4 66  4 23,844  1890
44  3*,y 51*,y 239  7 85 118  2* 62  1* 28,038  821*
17  9z 22z 157  71 56 60  23z 38  14z,x 15,378  7221
18  4 20 195  15 69 96  4 67  2 18,858  1857
31  4 39 217  14 78 109  4 66  1k 23,598  1413
38  2 44 286  15 100 108  2 68  1 30,663  1438
55  3* 63 * 277  9 98 114  3* 63  2 31,498  531
29  8 37 228  43 81 89  15 59  9 23,153  4970
36  5 40 243  14 86 109  4 68  1 26,401  1257
39  3 49 261  16 94 113  3 64  2 29,039  1072
39  1 45 290  13 102 105  3 68  1 30,265  1018
57  2*,y 66*,y 284  8 101 114  3* 62  1 32,661  955*
31  9 39 238  46 84 88  15z 60  9 22,147  4874
38  6 42 274  9 96 106  3 67  2 28,581  986
40  3 50 272  14 97 113  3 64  2 30,021  991
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S44% and 45% of prearrest values, respectively, whereas the
AL rewarming strategy increased from 51% (10 minutes) to
63% and 66% of prearrest CO at 30 and 60 minutes of re-
perfusion. Because in the isolated working rat heart prepara-
tion CO is the sum of AF and CF, the CO reflects the changes
in AF and CF. A point of emphasis is that cold Celsior hearts
rewarmed with Celsior returned only 4% and 22% CO at
5 and 10 minutes of reperfusion. At 30 minutes, the CO
for this group increased nearly 2-fold (37% of prearrest
value) and did not increase further at 60 minutes (39% of
prearrest value). In contrast, if cold Celsior hearts were re-
warmed with AL cardioplegia, the return of CO was more
rapid and significantly higher (up to 11 times) at 5 minutes
compared with Celsior and KH rewarming (Table 1). At
10 minutes, the cold Celsior hearts with AL rewarming re-
turned a CO of 39% of prearrest value, 49% of prearrestThe Journal of Thoracic and Carvalue at 30 minutes, and 50% of prearrest value at 60 min-
utes of reperfusion (Table 1).
Recovery of Heart Rate
At 5 minutes after switching from Langendorff rewarm-
ing to working mode, the cold AL group with KH rewarming
or AL rewarming spontaneously returned a heart rate of 228
and 109 beats/min, respectively (Table 1 and Figure 2, C).
The higher rate for the KH rewarming group at 5 minutes
was significant and was due to them already beating in Lan-
gendorff mode. After 10 minutes, there was no significant
difference between the KH or AL rewarming strategies
(242 vs 239 beats/min). At 30 minutes, both rewarming
groups increased their heart rates by around 17% and an
additional 3% at 60 minutes (Table 1). There were no signif-
icant differences between these 2 groups from 10 todiovascular Surgery c Volume 141, Number 4 1049
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FIGURE 2. A, Percentage recovery of aortic flow (AF) during 60 minutes
of reperfusion in working mode immediately after 5 minutes of different
oxygenated continuous reperfusion strategies in Langendorff mode. The
5 groups were as follows: (1) adenosine–lidocaine (AL; cold) with Krebs–
Henseleit (KH) rewarming (open squares); (2) AL (cold) with AL rewarm-
ing (solid squares); (3) Celsior (C; cold) with Celsior rewarming (open
circles); (4) Celsior (cold) with KH rewarming (open triangles), and (5)
Celsior (cold) with AL rewarming (solid circles). B, Percentage recovery
of coronary flow (CF) during 60 minutes of reperfusion in working
mode. C, Percentage recovery of heart rate (HR) during 60 minutes of reper-
fusion in working mode. Significance (P<.05) for panels A, B, and C was
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S60 minutes of reperfusion (Table 1 and Figure 2, C). In con-
trast, the heart rate for the cold Celsior hearts rewarmed with
Celsior was 38 beats/min at 5 minutes (13% of prearrest
value), and this poor return was dramatically improved if
cold Celsior hearts were rewarmed with KH or AL arrest so-
lution; the heart rate rapidly and spontaneously increased
from 38 beats/min to 178 to 197 beats/min for KH and AL
rewarming, respectively (63% to 70% of baseline value).
As with the cold AL group, there were no significant differ-
ences between rewarming with KH or AL cardioplegia in re-
turn of heart rate for the cold Celsior group, although the AL
rewarming group had 7% to 12% higher values at 5, 10, and
30 minutes (Table 1 and Figure 2, C).
Recovery of Systolic and Diastolic Pressures
The developed pressures for the different groups followed
similar patterns to those described for AFs. The cold Celsior
group rewarmed with Celsior failed to generate sufficiently
high pressures at 5 or 10 minutes compared with all other
groups, and these were reflected in lower rate–pressure prod-
ucts at the different reperfusion times (Table 1). At 10 min-
utes, the cold Celsior with Celsior rewarming group could
only generate a systolic/diastolic pressure of 60/38 mm
Hg. At 30 minutes, the systolic/diastolic pressures were
89/59 mm Hg, respectively, and at 60 minutes, they were
88/60 mm Hg (Table 1). Interestingly, a full return of dia-
stolic pressure occurred for this Celsior group at 30 minutes
of reperfusion; however, the highest return of systolic pres-
sure was only 70% of prearrest value (Table 1). The lower
developed pressures for the cold Celsior with Celsior re-
warming group were also reflected in lower rate–pressure
products at the different reperfusion times (Table 1).
The rate–pressure product is often used as a predictor of
MVO2 value under different contractile states in experimen-
tal and clinical studies. Total tissue water for the cold AL
with KH or with AL rewarming groups were 88% 
0.5% and 89%  1%, respectively. Total tissue water for
cold Celsior with Celsior rewarming was 86%  2%, for
Celsior with KH rewarming was 88%  0. 4%, and for
Celsior with AL rewarming was 87%  0.4% (P< .05).MVO2 Value
The mean value for the prearrest MVO2 in working mode
was 37.6  0.8 mmol O2/min/g dry weight (n ¼ 48, see the
Materials and Methods section). At the end of the rewarming
phase, the MVO2 values for the cold AL preservation groupsas follows: *AL (cold) with AL (rewarming) and Celsior (cold) with Celsior
(rewarming); yAL (cold) with AL (rewarming) and AL (cold) with KH (re-
warming); xCelsior (cold) with Celsior (rewarming) and Celsior (cold) with
AL (rewarming); #Celsior (cold) with Celsior (rewarming) and Celsior
(cold) with KH (rewarming); zCelsior (cold) with AL (rewarming) and
Celsior (cold) with KH (rewarming).
:
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FIGURE 3. A, Myocardial oxygen consumption (MVO2) values for the 5
different groups during the 5-minute rewarming period in Langendorff
mode and at 10 and 60 minutes of reperfusion in working mode. The prearr-
est MVO2 value was a mean from 48 hearts taken from Rudd and Dobson
6
(see the Materials and Methods section for details). Significance (P< .05)
was as follows: *adenosine–lidocaine (AL; cold) with AL (rewarming)
and Celsior (C; cold) with Celsior (rewarming); yAL (cold) with AL (re-
warming) and AL (cold) with Krebs–Henseleit (KH; rewarming). B (i), Lac-
tate output measured in the last minute of the 5-minute rewarming period in
the different groups immediately before switching the heart from Langen-
dorff mode to working mode. Significance (P< .05) was as follows: *Cel-
sior (cold) with Celsior (rewarming) was significantly higher than any other
group. B (ii), Effluent pH measured in the last minute of the 5-minute re-
warming period in the different groups immediately before switching the
heart from Langendorff mode to working mode. Significance (P< .05)
was as follows: *Celsior (cold) with Celsior (rewarming) was significantly
lower than any other group. C, Adenosine triphosphate (ATP) production in
the last minute of the 5-minute rewarming period calculated from oxygen
consumption and lactate production (see the Materials and Methods for
equations). The white vertical bars represent the aerobic component to total
ATP generation/replenishment, and the dark sections represent the anaero-
bic component in micromoles of ATP per minute per gram of dry weight.
Significance (P<.05) was as follows: *Celsior (cold) with Celsior (rewarm-
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and 18.6  1.0 mmol O2/min/g dry weight, respectively
(Figure 3, A). The MVO2 values for the cold Celsior group
rewarmed with Celsior, KH, or AL arrest were 11.7  1.2,
20.9  2.7, and 13.4  1.5 mmol O2/min/g dry weight, re-
spectively (Figure 3, A). The coronary effluent flows in the
final minute for the cold AL (KH and AL rewarming) groups
were 12.8  0.9 and 13.6  0.4 mL, respectively, and those
for the cold Celsior (Celsior, KH, and AL rewarming)
groups were 11.0  0.8, 12.2  0.6, and 11.2  0.9 mL, re-
spectively. During reperfusion in working mode at 10 and 60
minutes, the MVO2 values for the cold AL group reperfused
with KH was 27.1  1.9 and 28.7  1.8 mmol O2/min/g dry
weight, and that for the cold AL with AL rewarming group
was slightly higher at 10 minutes (32.7  4 mmol O2/min/g
dry weight) and 1.6 times higher at 60 minutes (46.6  4.9
mmol O2/min/g dry weight; Figure 3, A). The MVO2 values
for the cold Celsior with Celsior rewarming group at 10 and
60 minutes of working mode were 17  6.0 and 33.1  6.0
mmol O2/min/g dry weight, respectively; those for the cold
Celsior plus KH rewarming group were 19.0  2.3 and
21.9  2.8 mmol O2/min/g dry weight, respectively; and
those for the cold Celsior plus AL rewarming group were
27.1  2.4 and 27.3  2.7 mmol O2/min/g dry weight,
respectively (Figure 3, A).T
/B
SLactate Output and ATP Production
The lactate outputs for the cold AL group with KH or AL
rewarming were 1.09  0.43 and 1.13  0.51 mmol lactate/
min/g dry weight (Figure 3, B, i). In contrast, lactate produc-
tion in the cold Celsior with Celsior rewarming group was
nearly an order of magnitude higher at 9.79  3.7 mmol lac-
tate/min/g dry weight but not when rewarmed with KH or
AL, at which values were 0.98  0.64 and 1.12  0.31
mmol lactate/min/g dry weight, respectively. Effluent pH
values measured during the last minute of the 5-minute re-
warming period are shown in Figure 3, B, ii. The pH in 4
of the 5 groups was around 7.37 to 7.43, with the exception
of the cold Celsior with Celsior rewarming group, which had
nearly a 7.5-fold increase in hydrogen ion concentration
(a decrease in pH from 7.4 to 6.5  0.16).
The total ATP produced (aerobic and anaerobic) in the
last minute of the 5-minute rewarming reperfusion period
is shown in Figure 3, C. Values for the cold AL with KH
or AL rewarming groups were 136  10 and 118  5
mmol ATP/min/g dry weight, respectively, and for the cold
Celsior with Celsior, KH, or AL rewarming groups,
the values were 98  12, 111  21, and 95  3 mmol
ATP/min/g dry weight, respectively (Figure 3, C). Of theing) showed significantly higher ATP values from anaerobic glycogenolysis
than any other group.
:
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AL with KH or AL rewarming groups were 1.5% and 1.7%,
and for the cold Celsior with Celsior, KH, or AL rewarming
groups, the percentages were 19.4%, 0.9%, and 2.1% of the
total ATP produced. The anaerobic production of ATP was
significantly higher in the cold Celsior with Celsior rewarm-
ing group than in any other group and more than 10-fold
higher than with cold Celsior reanimated with AL arrest
solution.
DISCUSSION
Transferring the donor heart from a cold depolarizing
storage environment to a warm environment for arousal
and implantation predisposes the myocardium, vascular en-
dothelium, and electrical conduction system to instability,
which can contribute to graft injury and possible rejec-
tion.1–3 Our study focused on the effect of rewarming
donor hearts with polarizing and depolarizing reperfusion
solutions after 6 hours of cold static storage. We report
that rewarming the heart with oxygenated, polarizing AL
arrest solution significantly increased AFs and CFs and
developed pressures compared with KH rewarming alone.
In addition, rewarming cold depolarizing Celsior hearts
with AL arrest solution significantly increased reliance on
aerobic versus anaerobic metabolism, with nearly an order
of magnitude lower lactate values and no acidosis and
faster times to higher spontaneous flows compared with
those hearts rewarmed with depolarizing Celsior solution.
Polarizing AL cardioplegia might have clinical
significance to reduce the different facets of stunning
during cold-to-warm transitions in heart transplantation
and cardiac surgery.
Rewarming With Polarizing AL Solution After Cold
Static Storage
Hearts stored for 6 hours at 4C in cold AL arrest solution
and rewarmed with AL recovered 1.6 times the AF, 1.2
times the CF, and 1.5 times the CO than hearts rewarmed
with KH alone (AL vehicle) at 60 minutes of reperfusion
(Table 1). The cold Celsior rewarmed with Celsior group
was suboptimal, and its slow and poor recovery was partially
reversed with KH or AL rewarming strategies (Figure 2, A
and B). It was concluded that rewarming the depolarized
or polarized 4C hearts in AL, oxygenated, polarized arrest
solution resulted in less ischemia–reperfusion injury (Table
1 and Figures 2 and 3). Interestingly, recovery of heart rate
from cold hearts was not significantly different between AL
and KH rewarming (Table 1), indicating that polarizing nor-
mokalemic conditions per se without AL provided equiva-
lent protection of the cardiac pacemaker and possibly the
conduction system. However, the AL rewarming group con-
sistently showed 7% to 12% higher heart rates at 5, 10, and
30 minutes than seen with KH rewarming alone (Table 1 and
Figure 2, C).1052 The Journal of Thoracic and Cardiovascular SurEffect of 5 Minutes of AL Warm Reperfusion on
MVO2 Values
In addition to improved working left ventricular and cor-
onary function, rewarming cold AL hearts in nonworking
Langendorff mode with AL arrest solution resulted in a rela-
tively high MVO2 value. This high MVO2 value was associ-
ated with a 1.6-fold higher maintenance metabolism than for
cold Celsior hearts rewarmed with either Celsior or AL
(Figure 3, A). Because MVO2 values in the cold Celsior re-
warmed with Celsior or AL group were not significantly dif-
ferent (11.72 vs 13.39 mmol O2/min/g dry weight), the
higher MVO2 value in the cold AL hearts rewarmed with
AL is likely the result of the antecedent polarized AL arrest
in cold static storage. In summary, a normokalemic, polar-
ized AL storage environment combined with oxygenated
AL rewarming reperfusion led to higher MVO2 values be-
fore switching to working mode, and this strategy appears
to be more cardioprotective than all other treatment groups.
Another interesting finding during the last minute of re-
warming was that the cold AL group with nonarrest KH
alone (the vehicle of AL arrest solution) increased MVO2
values by only 30% (23.9  2.5 mmol O2/min/g dry weight)
compared with AL rewarming alone (Figure 3, A). The KH
group was a nonworking beating heart, and the higher
MVO2 value was not due to higher CF because the effluent
flow was 12.8 mL/min at 5 minutes of rewarming compared
with 13.6 mL/min for AL-arrested hearts. We conclude that
the extra 30% O2 consumed in KH-rewarmed hearts was
largely derived from greater myocardial mitochondrial me-
tabolism and O2 extraction and not from changes in coronary
vascular resistance. Normally, cardiac maintenance or basal
metabolism represents about 20% to 30% of the total en-
ergy flux15; however, the maintenance metabolism for cold
arrest with KH rewarming appeared to be about 70% based
on the contribution from AL arrest. As early as 1986, Allen
and colleagues16 reported that the best myocardial recovery
after global ischemia in dogs occurred when the heart con-
sumed oxygen in excess of basal demands; our data would
support this observation. Further studies are required during
this critical rewarming/reperfusion period after cold static
storage.
Possible Reasons for the High Maintenance
Metabolism During Rewarming
In 1997, Lawton and coworkers17 reported a higher
MVO2 value in isolated rabbit hearts during early reperfu-
sion from 30 minutes of global arrest in hyperpolarizing pi-
nacidil compared with depolarizing St Thomas Hospital
solution. No postarrest functional differences were found be-
tween the 2 groups. Lawton and coworkers suggested that
the higher MVO2 value after hyperpolarized arrest might
be related to reparative processes or to a higher oxygen
debt generated during ischemia. In our study the higher
MVO2 value in cold AL hearts with AL rewarming doesgery c April 2011
Rudd and Dobson Evolving Technology/Basic Science
E
T
/B
Snot appear to be related to repayment of oxygen debt because
there was no excess lactate efflux or no metabolic acidosis
(pH 7.4; Figure 3, B). Nor does the higher MVO2 appear
to arise from reparative O2-consuming processes of viable
myocytes because polarizing AL cardioplegia and rewarm-
ing showed superior functional recoveries compared with
those of any other group (Figure 2). The higher MVO2 value
during rewarming polarized arrest is more likely linked to
improved mitochondrial oxidative replenishment of ATP
to support a new maintenance steady-state metabolism.
This new steady state in cold AL and AL-rewarmed hearts
we believe is a restorative response to the rewarming oxy-
genation challenge and not a reparative response to ische-
mia–reperfusion injury because the lactate value was low
and the effluent pH was 7.4. Adenosine might have assisted
in purine salvage and maintenance of the adenylate pools
within the myocardium and in stabilizing ATP.18,19
Further experiments are required to test these rewarming
hypotheses and to test the effect of different durations of re-
perfusion and doses of AL in crystalloid and blood during
the early rewarming phase. It would also be of interest to mea-
sure MVO2 values during cold static storage and transition to
normothermic conditions, continuing for the entire rewarm-
ing–reperfusion period. For logistical reasons, it is difficult
to measure MVO2 values during cold static storage. Dobson
and Jones5,9 calculated MVO2 values in Langendorff arrested
rat hearts during 2-minute normothermic infusions of AL
cardioplegia over a 4-hour arrest period and reported values
of between 6 and 8 mmol O2/min/g dry weight for coronary
effluent perfusate flows of 10 to 14 mL/min. In the present
study the AL–rewarmed/arrested hearts had MVO2 values
2.6 times this value for maintenance metabolism at 5
minutes of oxygenated reperfusion (Figure 3, A).
Effect of Rewarming With Polarized AL Arrest
Solution and Possible Prevention of Stunning
One of the most striking results was the effect of rewarm-
ing on stunning in the Celsior group. In cold Celsior hearts
there was a significant delay in the spontaneous return of
AFs and CFs (Figure 2, A and B) and a delay in return of si-
nus rhythm. After switching to working mode, the heart rate
was highly variable and significantly lower during early and
late reperfusion in this group (Figure 2, C). These subopti-
mal outcomes are consistent with Celsior-related myocar-
dial, vascular, and electrical stunning. Stunning is defined
as the loss of postoperative contractility during reperfusion
without cell death.20 These early functional deficits were
not found if Celsior rewarming was replaced with a polariz-
ing AL rewarming strategy (Table 1 and Figure 2, A and B),
which implicates depolarizing hyperkalemia as a possible
cause. Stunning in Celsior hearts was also associated with
significant 9-fold higher lactate efflux and significantly
lower effluent pH (pH 6.5) before switching to working
mode (Figure 3, B and C). The higher lactate efflux andThe Journal of Thoracic and Caracidic pH at the 5-minute rewarming period was not due
changes in effluent CFs because they were 11.0 mL/min ver-
sus 12.2 mL/min for the cold Celsior with Celsior rewarming
and cold Celsior with KH rewarming groups, respectively.
The anaerobic production of ATP in the cold Celsior with
Celsior rewarming group was also significantly higher
than in any other group and more than 10-fold higher than
in the cold Celsior rewarmed with AL arrest solution group.
This result in Celsior hearts is significant because Neely and
associates21 showed in isolated rat hearts that the decrease in
contractile force of ischemic hearts was also associated with
increased tissue lactate values.22
In a human transplantation study using Celsior cold preser-
vation, Wildhirt and colleagues23 also reported myocardial
and possibly endothelial stunning. They reported greater ino-
tropic support within the first 5 postoperative days in patients
receiving the Celsior-preserved donor hearts and a significant
correlation between longer ischemic times in the Celsior
group and reduced CF reserve, implicating endothelial dys-
function. Endothelin and inducible nitric oxide synthase
gene expression were significantly higher in the Celsior
group.23 Ventricular stunning is common in postimplantation
denervated donor hearts and a key contributor to early graft
failure during the first 30 days after transplantation.24-26 In
summary, cold Celsior hearts reperfused for 5 minutes at
37C before reanimation with warm AL cardioplegia
showed no stunning when compared with hearts rewarmed
with Celsior arrest solution alone. The possible reasons
for improved spontaneous return of function after
normokalemic, polarizing, oxygenated AL rewarming arrest
include (1) return of myocardial and coronary vascular
membrane voltages to their normal operating limits, thereby
reducing Ca2þ loading and stunning5,7,10; (2) favoring
aerobic replenishment of ATP where there is no net
hydrogen ion production and less reliance on anaerobic
metabolism; and (3) possibly reduced production of
oxygen-derived free radicals and other oxidants compared
with hyperkalemic depolarized myocytes and activated endo-
thelial cells during rewarming and reperfusion.27
Clinical Significance
During organ storage, rewarming, and implantation, the
donor heart enters and emerges from a hostile, cold depola-
rizing environment where it is subjected to unnatural
changes in cell membrane voltage and ionic and metabolic
imbalances. In the early 1990s, Wheeldon and coworkers28
from the Papworth Hospital reported that some form of re-
perfusion was used 55% of the time in 92 transplantation
centers worldwide, and most used intermittent doses of
cold blood or cold hyperkalemic, oxygenated, depolarizing
crystalloid cardioplegia during implantation followed by
normothermic blood reperfusion. In 1996, Pradas and asso-
ciates29 showed in human transplantation that continuous
warm reperfusion was technically feasible and appeared todiovascular Surgery c Volume 141, Number 4 1053
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methods were largely translated from the extensive preclin-
ical and clinical studies of Buckberg’s group and Mena-
sche’s group after cardioplegic arrest16,30 and from which
the more targeted concept of controlled reperfusion was
developed.22,31
The present study has added another new concept and pos-
sible strategy for rewarming and reperfusing the donor heart.
The strategy is rewarming with normokalemic, oxygenated,
polarizing AL arrest solution. Cold or warm hyperkalemic
depolarizing cardioplegia, combined with the effects of is-
chemia, acidosis, and temperature shifts, predisposes the
heart to electrical and mechanical instability during reperfu-
sion, which can lead to postoperative stunning.5,18,29,32 In
contrast, restoring the heart’s cell membrane potentials to
their normal operational limits within the myocardium,
with intact transmural and regional ionic heterogeneities,
might promote a more electrically and mechanical stable
heart. The new AL cold–warm normokalemic reperfusion
strategy might also find utility in portable perfusion
apparatuses by using controlled, low-pressure infusions to
preserve the human donor heart.33,34 In summary, evolving
technologies to minimize damage during rewarming and
implantation of donor hearts and other organs include the
following: (1) temperature control, (2) hemodynamic
control (unloaded nonworking mode), (3) pressure control,
and (4) reperfusate control.1,3,22,35 We propose a fifth
strategy, namely membrane voltage control with
normokalemic polarizing strategies.
Limitations of the Study and Future Directions
The rat heart model of cold static storage and rewarming
differs from heart transplantation in a number of ways. Al-
though both rat and human hearts are empty and nonworking
in the physical sense and are perfused through the coronary
vessels after storage, the rat heart in working mode has
preload and afterload that are preset during normothermic
reperfusion. In contrast, during weaning off cardiopulmo-
nary bypass, the preload and afterload of the human donor
heart are dynamic variables in which preload is determined
by a balance of blood volume between the patient and oxy-
genator and afterload is dependent on the status of peripheral
vascular resistance and CO. However, the rat model is still
clinically relevant because myocardial and coronary vascu-
lar injury does occur in the human graft during early rewarm-
ing and reperfusion. Future studies are required to include
patch-clamp methods, voltage measurements, immunohisto-
chemistry, and testing of the AL reperfusion strategy in
larger animal models combined with myocardial and endo-
thelial injury biomarkers, such as troponins; inflammatory
and procoagulative indices; and potential markers of pri-
mary graft dysfunction, such as hypoxia-inducible factor
and donor serum protein concentration of SMARCAL11054 The Journal of Thoracic and Cardiovascular Sur(SWI/SNF-related matrix-associated actin-dependent regu-
lator of chromatin subfamily A–like protein 1).36CONCLUSIONS
Early continuous reperfusion with warm, oxygenated,
normokalemic polarizing AL cardioplegia improved sponta-
neous functional recovery after 6 hours of cold static storage
in the isolated rat heart. Rewarming cold Celsior hearts with
AL solution appeared to reduce myocardial and microvascu-
lar stunning. The normokalemic AL arrest and preservation
solution might find utility during cold-to-warm wash transi-
tions and implantation of donor hearts.
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